HomeAbout

TL;DR CNBC


GlaxoSmithKline to widen coronavirus antibody treatment trial after safety clearance - TL;DR CNBC

GlaxoSmithKline to widen coronavirus antibody treatment trial after safety clearance

Publishing timestamp: 2020-10-06 12:15:03


Summary


Sentiment: NEGATIVE

Tickers: VIRGSK-GB

Keywords:

Source: https://www.cnbc.com/2020/10/06/glaxosmithkline-to-widen-coronavirus-antibody-treatment-trial-after-safety-clearance.html


Developed by Leo Phan